1. Anonymous Assesment report for Cimzia. Procedure No EMEA/H/C/001037 www.emea.europa.eu/humandocs/PDFs/EPAR/cimzia/H-1037-en6.pd 2009 1 47
2. CDP870 a novel, humanised tumour necrosis factor alpha inhibitor improves HRQOL. Late breaking abstract;Emery,2002
3. CDP870, A novel pegylated, humanized TNF-alpha inhibitor, is effective in treating the signs and symptoms of rheumatoid arthritis (RA);Keystone,2001
4. Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX;Choy;Rheumatology (Oxford),2012
5. UCB Clinical Study Summary Study No.: CDP870-014 http://www.clinicalstudyresults.org/documents/company-study_4348_0.pdf 2008